Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Clinical trial NCT00603356 · COMPLETED

Trial details

NCT number: NCT00603356
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2007-11-01
Primary completion: 2010-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.